YHB Investment Advisors Inc. Increases Holdings in UnitedHealth Group Inc (UNH)

YHB Investment Advisors Inc. raised its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 71.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 37,486 shares of the healthcare conglomerate’s stock after acquiring an additional 15,578 shares during the period. UnitedHealth Group makes up about 1.3% of YHB Investment Advisors Inc.’s portfolio, making the stock its 23rd biggest position. YHB Investment Advisors Inc.’s holdings in UnitedHealth Group were worth $7,342,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. BlackRock Inc. lifted its stake in shares of UnitedHealth Group by 1.2% in the 2nd quarter. BlackRock Inc. now owns 69,430,416 shares of the healthcare conglomerate’s stock valued at $12,873,786,000 after purchasing an additional 796,654 shares during the period. Vanguard Group Inc. lifted its stake in shares of UnitedHealth Group by 2.5% in the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after purchasing an additional 1,588,516 shares during the period. FMR LLC lifted its stake in shares of UnitedHealth Group by 2.1% in the 2nd quarter. FMR LLC now owns 56,101,668 shares of the healthcare conglomerate’s stock valued at $10,402,371,000 after purchasing an additional 1,168,324 shares during the period. Alliancebernstein L.P. lifted its stake in shares of UnitedHealth Group by 2.3% in the 2nd quarter. Alliancebernstein L.P. now owns 7,906,936 shares of the healthcare conglomerate’s stock valued at $1,466,104,000 after purchasing an additional 174,290 shares during the period. Finally, TIAA CREF Investment Management LLC lifted its stake in shares of UnitedHealth Group by 3.9% in the 2nd quarter. TIAA CREF Investment Management LLC now owns 5,882,427 shares of the healthcare conglomerate’s stock valued at $1,090,720,000 after purchasing an additional 223,524 shares during the period. Institutional investors and hedge funds own 86.01% of the company’s stock.

In other news, insider Thomas E. Roos sold 975 shares of the company’s stock in a transaction on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total transaction of $200,333.25. Following the completion of the sale, the insider now owns 24,630 shares of the company’s stock, valued at $5,060,726.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Larry C. Renfro sold 22,598 shares of the company’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the sale, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at approximately $43,310,879.50. The disclosure for this sale can be found here. Insiders have sold 34,630 shares of company stock valued at $7,669,416 in the last ninety days. Insiders own 0.89% of the company’s stock.

Several equities analysts recently issued reports on the stock. Leerink Swann reiterated a “buy” rating and issued a $240.00 target price (up from $225.00) on shares of UnitedHealth Group in a research note on Wednesday, October 18th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 target price for the company in a research note on Thursday, September 21st. Cantor Fitzgerald boosted their target price on shares of UnitedHealth Group to $225.00 and gave the company an “overweight” rating in a research note on Wednesday, October 18th. Oppenheimer boosted their target price on shares of UnitedHealth Group from $215.00 to $205.00 and gave the company an “outperform” rating in a research note on Wednesday, October 18th. Finally, Wells Fargo & Co reiterated an “outperform” rating and issued a $245.00 target price (up from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Three research analysts have rated the stock with a hold rating and twenty-five have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $226.74.

Shares of UnitedHealth Group Inc (NYSE UNH) opened at $224.20 on Thursday. The company has a market cap of $216,770.00, a price-to-earnings ratio of 25.48, a P/E/G ratio of 1.57 and a beta of 0.66. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. UnitedHealth Group Inc has a 1-year low of $156.09 and a 1-year high of $231.77.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping the consensus estimate of $2.57 by $0.09. The company had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.17 EPS. analysts expect that UnitedHealth Group Inc will post 9.99 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Friday, December 1st were issued a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.34%. The ex-dividend date of this dividend was Thursday, November 30th. UnitedHealth Group’s payout ratio is presently 34.09%.

COPYRIGHT VIOLATION NOTICE: “YHB Investment Advisors Inc. Increases Holdings in UnitedHealth Group Inc (UNH)” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another site, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/01/11/yhb-investment-advisors-inc-increases-holdings-in-unitedhealth-group-inc-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply